{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:12Z","timestamp":1792791492266,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.intimp.2026.117595","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:03:02Z","timestamp":1792728182000},"page":"117595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["GM2A links keratinocyte metabolism to inflammation in psoriasis: Integrated transcriptomic and functional analyses"],"prefix":"10.1016","volume":"191","author":[{"given":"Yixuan Wang","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaijie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2026.117595_bb0005","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","article-title":"Psoriasis prevalence in adults in the United States","volume":"157","author":"Armstrong","year":"2021","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.intimp.2026.117595_bb0010","doi-asserted-by":"crossref","first-page":"adv42945","DOI":"10.2340\/actadv.v105.42945","article-title":"Epidemiology of psoriasis: a worldwide global study","volume":"105","author":"Skayem","year":"2025","journal-title":"Acta Derm. Venereol."},{"issue":"10281","key":"10.1016\/j.intimp.2026.117595_bb0015","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2026.117595_bb0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.intimp.2026.117595_bb0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40257-024-00874-z","article-title":"Sequencing of targeted therapy in psoriasis: does it matter?","volume":"25","author":"Boswell","year":"2024","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.intimp.2026.117595_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1250504","article-title":"Multi-omics segregate different transcriptomic impacts of anti-IL-17A blockade on type 17 T-cells and regulatory immune cells in psoriasis skin","volume":"14","author":"Kim","year":"2023","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117595_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126561","article-title":"Aberrations in lipid expression and metabolism in psoriasis","volume":"22","author":"Nowowiejska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2026.117595_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2024.103098","article-title":"Epidemiology of lipid disturbances in psoriasis: an analysis of trends from 2006 to 2023","volume":"18","author":"Zhang","year":"2024","journal-title":"Diabetes Metab. Syndr."},{"issue":"8","key":"10.1016\/j.intimp.2026.117595_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.71128","article-title":"A common genetic background for psoriasis and cardiovascular diseases: a narrative review","volume":"8","author":"Lazar","year":"2025","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.intimp.2026.117595_bb0050","article-title":"Skin barrier dysfunction and correlation with the onset and progression of psoriasis","volume":"17","author":"Wang","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117595_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.961107","article-title":"Current knowledge of the implication of lipid mediators in psoriasis","volume":"13","author":"Simard","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117595_bb0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13024-022-00558-4","article-title":"Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity","volume":"17","author":"Hsieh","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.intimp.2026.117595_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25051130","article-title":"Unbalanced sphingolipid metabolism and its implications for the pathogenesis of psoriasis","volume":"25","author":"Boche\u0144ska","year":"2020","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.intimp.2026.117595_bb0070","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143397","article-title":"ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance","volume":"132","author":"Jiang","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.intimp.2026.117595_bb0075","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/thoraxjnl-2021-217674","article-title":"Novel genetic variants associated with inhaled corticosteroid treatment response in older adults with asthma","volume":"78","author":"Wang","year":"2023","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.intimp.2026.117595_bb0080","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-026-07963-z","article-title":"TRIM7-mediated autophagy-lysosomal signaling is essential for preimplantation development in mice","volume":"24","author":"Khan","year":"2026","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117595_bb0085","doi-asserted-by":"crossref","first-page":"7627","DOI":"10.1038\/s41598-019-43952-7","article-title":"A low-carbohydrate ketogenic diet promotes ganglioside synthesis via the transcriptional regulation of ganglioside metabolism-related genes","volume":"9","author":"Okuda","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.117595_bb0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.molimm.2025.04.006","article-title":"Steap3 is a key node in regulating the phagosome escape of listeria monocytogenes","volume":"182","author":"Li","year":"2025","journal-title":"Mol. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2026.117595_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2022.104999","article-title":"Label-free quantitative proteomics reveals the Steap3-Gm2a axis inhibiting the phagosomal escape of listeria monocytogenes","volume":"24","author":"Yuan","year":"2022","journal-title":"Microbes Infect."},{"issue":"1","key":"10.1016\/j.intimp.2026.117595_bb0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13195-019-0533-9","article-title":"Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease","volume":"11","author":"Sj\u00f6din","year":"2019","journal-title":"Alzheimer's Res. Ther."},{"issue":"7","key":"10.1016\/j.intimp.2026.117595_bb0105","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100081RR","article-title":"Proteomics and bioinformatics reveal insights into neuroinflammation in the acute to subacute phases in rat models of spinal cord contusion injury","volume":"35","author":"Yao","year":"2021","journal-title":"FASEB J."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2026.117595_bb0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymgme.2018.07.005","article-title":"The GM2 ganglioside inhibits iNKT cell responses in a CD1d-dependent manner","volume":"125","author":"Pereira","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.intimp.2026.117595_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134425","article-title":"GBM derived gangliosides induce T cell apoptosis through activation of the caspase Cascade involving both the extrinsic and the intrinsic pathway","volume":"10","author":"Mahata","year":"2015","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.intimp.2026.117595_bb0120","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.4049\/jimmunol.0900259","article-title":"Elevated levels of select gangliosides in T cells from renal cell carcinoma patients is associated with T cell dysfunction","volume":"183","author":"Biswas","year":"2009","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117595_bb0125","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2249.2002.02006.x","article-title":"Gangliosides inhibit the development from monocytes to dendritic cells","volume":"130","author":"W\u00f6lfl","year":"2002","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117595_bb0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12964-023-01381-0","article-title":"Triggers for the onset and recurrence of psoriasis: a review and update","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"4","key":"10.1016\/j.intimp.2026.117595_bb0135","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s40257-025-00949-5","article-title":"Disease modification in psoriasis: future prospects for long-term remission","volume":"26","author":"Ranzinger","year":"2025","journal-title":"Am. J. Clin. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117595_bb0140","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.intimp.2026.117595_bb0145","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1016\/j.jid.2024.09.012","article-title":"Curing Psoriasis","volume":"144","author":"Lwin","year":"2024","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117595_bb0150","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jdv.18044","article-title":"Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis","volume":"36","author":"Wu","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117595_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13020291","article-title":"Abnormalities of sphingolipids metabolic pathways in the pathogenesis of psoriasis","volume":"13","author":"Burger","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.intimp.2026.117595_bb0160","article-title":"GM2 activator deficiency: an ultra-rare disorder with a new case and review of 22 published cases","volume":"43","author":"Yolda\u015f \u00c7elik","year":"2025","journal-title":"Mol Genet Metab Rep"},{"issue":"6","key":"10.1016\/j.intimp.2026.117595_bb0165","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.4049\/jimmunol.148.6.1753","article-title":"Gangliosides suppress tumor necrosis factor production in human monocytes","volume":"148","author":"Ziegler-Heitbrock","year":"1992","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117595_bb0170","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1471-4159.2010.07067.x","article-title":"Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside-deficient mutant mice","volume":"116","author":"Ohmi","year":"2011","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.intimp.2026.117595_bb0175","doi-asserted-by":"crossref","first-page":"E336","DOI":"10.1073\/pnas.1114965109","article-title":"CD4 and CD8 T cells require different membrane gangliosides for activation","volume":"109","author":"Nagafuku","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.117595_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.918346","article-title":"Pathophysiological significance of GM3 ganglioside molecular species with a particular attention to the metabolic syndrome focusing on toll-like receptor 4 binding","volume":"9","author":"Inokuchi","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"17","key":"10.1016\/j.intimp.2026.117595_bb0185","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1111\/febs.16076","article-title":"Homeostatic and pathogenic roles of the GM3 ganglioside","volume":"289","author":"Inokuchi","year":"2022","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.intimp.2026.117595_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11041067","article-title":"Exploring pro-inflammatory immunological mediators: unraveling the mechanisms of Neuroinflammation in lysosomal storage diseases","volume":"11","author":"Pandey","year":"2023","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.intimp.2026.117595_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021113","article-title":"Molecular mechanisms in pathophysiology of Mucopolysaccharidosis and prospects for innovative therapy","volume":"25","author":"Ago","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.117595_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2026.109905","article-title":"Tay-Sachs disease models: from cellular and animal models to treatment perspectives","volume":"148","author":"Suarez","year":"2026","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.intimp.2026.117595_bb0205","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1091\/mbc.10.2.313","article-title":"Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures","volume":"10","author":"Rusnati","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.intimp.2026.117595_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108024","article-title":"Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies","volume":"233","author":"Sumaiya","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2026.117595_bb0215","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5590","article-title":"Macrophage migration inhibitory factor: exploring physiological roles and comparing health benefits against oncogenic and autoimmune risks (review)","volume":"56","author":"Camacho Meza","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2026.117595_bb0220","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cytogfr.2026.07.002","article-title":"The functional roles of macrophage migration inhibitory factor in the tumor microenvironment","volume":"91","author":"Xu","year":"2026","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"10.1016\/j.intimp.2026.117595_bb0225","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s40257-025-00977-1","article-title":"Management of Erythrodermic Psoriasis with systemic therapies: a systematic review","volume":"26","author":"Mastorino","year":"2025","journal-title":"Am. J. Clin. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117595_bb0230","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jaad.2023.05.074","article-title":"Systemic calcineurin inhibitors tacrolimus and voclosporin: a review of off-label dermatologic uses","volume":"90","author":"Dai","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117595_bb0235","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s40257-016-0211-7","article-title":"Considerations for systemic treatment of psoriasis in obese patients","volume":"17","author":"Gisondi","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117595_bb0240","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tiv.2014.12.016","article-title":"Integrating multiple omics to unravel mechanisms of Cyclosporin a induced hepatotoxicity in vitro","volume":"29","author":"Van den Hof","year":"2015","journal-title":"Toxicol. In Vitro"},{"issue":"3","key":"10.1016\/j.intimp.2026.117595_bb0245","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10787-025-02027-y","article-title":"Psoriasis beyond the skin: systemic inflammation as a bridge to metabolic and hepatic comorbidities","volume":"34","author":"Karmbir","year":"2026","journal-title":"Inflammopharmacology"},{"issue":"7","key":"10.1016\/j.intimp.2026.117595_bb0250","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2026.117595_bb0255","article-title":"IL-17A in psoriasis and beyond: cardiovascular and metabolic implications","volume":"10","author":"von Stebut","year":"2019","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117595_bb0260","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41584-024-01149-x","article-title":"Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases","volume":"20","author":"Buch","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117595_bb0265","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2026.2673285","article-title":"Unveiling the IL-17 axis: an immunometabolic bridge between psoriasis and metabolic syndrome","volume":"37","author":"Gisondi","year":"2026","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.intimp.2026.117595_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107879","article-title":"IL-17 as a therapeutic target in cardiovascular diseases: mechanistic insights and translational opportunities","volume":"219","author":"Ma","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.intimp.2026.117595_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/biom14080948","article-title":"Inflammation: is it a healer, confounder, or a promoter of Cardiometabolic risks?","volume":"14","author":"Tate","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.intimp.2026.117595_bb0280","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13075-025-03608-6","article-title":"Investigation of serum biomarkers in rheumatoid and psoriatic arthritis patients for disease-specific signatures","volume":"27","author":"Veale","year":"2025","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.intimp.2026.117595_bb0285","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/ATVBAHA.125.322533","article-title":"Direct Interleukin-6 inhibition blunts arterial thrombosis by reducing collagen-mediated platelet activation","volume":"45","author":"Ministrini","year":"2025","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117595_bb0290","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s12276-021-00649-0","article-title":"Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms","volume":"53","author":"Kang","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"19","key":"10.1016\/j.intimp.2026.117595_bb0295","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1111\/bph.70584","article-title":"The role of macrophage migration inhibitory factor (MIF) in the pathogenesis and progression of cardiovascular disease","volume":"183","author":"Mahabhashyam","year":"2026","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117595_bb0300","doi-asserted-by":"crossref","first-page":"247","DOI":"10.25259\/IJDVL_988_19","volume":"89","author":"Chhabra","year":"2023","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117595_bb0305","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","article-title":"The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp. Dermatol."},{"issue":"16","key":"10.1016\/j.intimp.2026.117595_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169063","article-title":"Psoriasis and Cardiometabolic diseases: shared genetic and molecular pathways","volume":"23","author":"Piaserico","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926014438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926014438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:46:27Z","timestamp":1792788387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926014438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":62,"alternative-id":["S1567576926014438"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117595","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GM2A links keratinocyte metabolism to inflammation in psoriasis: Integrated transcriptomic and functional analyses","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117595"}}